Back to search

Article

Pathological complete response to nivolumab, S1, oxaliplatin, and radiation in a patient with gastric cancer: A case report

2022-09-14

Abstract excerpt

BACKGROUND The addition of nivolumab to chemotherapy has proven to be superior as a first-line treatment for unresectable advanced or recurrent gastric cancer, and is currently considered the most effective treatment. The evidence for preoperative therapy is still insufficient. Here, we report the case of a patient with gastric cancer with hepatic invasion who underwent radical surgery after preoperative treatment...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d386b08-d8d9-5964-8db0-4a6d8f72fe84
DOI
10.21203/rs.3.rs-2050512/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pathological complete response to nivolumab, S1, oxaliplatin, and radiation in a patient with gastric cancer: A case reportDOI 10.21203/rs.3.rs-2050512/v1
Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.Semantic proximity
microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancerSemantic proximity
Phase II Feasibility Study of Adjuvant Chemotherapy With Docetaxel/Cisplatin/S-1 Followed By S-1 For Stage III Gastric CancerSemantic proximity
Preoperative chemoradiation-induced hematological toxicity and related vertebral dosimetry evaluations in patients with locally advanced gastric cancer: data from a phase III clinical trialSemantic proximity
Application of combined multiple organ resection in the treatment of locally advanced gastric cancerSemantic proximity
Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: A case report and literature review.Semantic proximity
Cetuximab combined with FOLFOX4 as the first-line treatment for advanced gastric cancer: report of 25 cases from a single institution.Semantic proximity
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case reportSemantic proximity
A case report of pathologically complete response of a huge rectal cancer after systemic chemotherapy with mFOLFOX6.Semantic proximity
The Comparison of the Short and Long-Term Outcomes Between Laparoscopic Total Gastrectomy and Open Total Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant ChemotherapySemantic proximity
Adebrelimab plus apatinib and SOX (AASOX) as conversion therapy for borderline resectable gastric cancer: a single-arm, single-centre, exploratory phase II studySemantic proximity
Select a neighboring publication to make it the new centre.